Stock listing

NASDAQ:NAUT Nautilus Biotechnology, Inc. Stock

Home listing (NASDAQ) of Nautilus Biotechnology, Inc.

Follow Nautilus Biotechnology, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:NAUT

$2.63 USD +0.57 (+27.7%)

Close on Oct 19, 2026

Past 3 months +52.9% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$1.97 – $2.68 USDOct 19, 2026
Volume
14.80M sharesOct 19, 2026
Market cap
$334.7M USDAt the close on Oct 19, 2026 · price × 127.3M shares outstanding
Nautilus Biotechnology, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NAUT · Home$2.63 USD+0.57 (+27.7%)14,804,486$2.02$2.68$1.97$2.06Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:NAUT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.63+0.57+27.7%$2.02$2.68$1.9714,804,486
$2.06-0.10-4.6%$2.17$2.23$1.996,409,693
$2.160.000.0%$2.07$2.20$1.888,502,195
$2.16+0.11+5.4%$2.00$2.19$1.918,129,587
$2.05-0.12-5.5%$2.125$2.34$2.007,326,791
$2.17-0.08-3.6%$2.165$2.25$1.8613,272,989
$2.25+0.43+23.6%$1.93$2.46$1.8519,575,734
$1.82-0.14-7.1%$2.00$2.01$1.756,605,640
$1.96+0.19+10.7%$1.67$2.17$1.6212,527,994
$1.77-0.10-5.3%$1.89$2.09$1.72511,022,100
$1.87-0.09-4.6%$2.185$2.475$1.8129,556,100
$1.96+0.39+24.8%$1.65$1.97$1.59814,189,800
$1.57+0.15+10.6%$1.43$1.676$1.388,507,800
$1.42+0.055+4.0%$1.46$1.49$1.2912,786,300
$1.365+0.255+23.0%$1.19$1.595$1.0822,392,100
$1.11+0.147+15.3%$1.00$1.17$0.994,102,500
$0.963-0.028-2.8%$1.00$1.04$0.962681,500
$0.991+0.037+3.9%$0.94$1.01$0.94518,800
$0.954-0.045-4.5%$1.00$1.02$0.95386,700
$0.999+0.044+4.6%$0.96$1.02$0.95606,800
$0.955-0.011-1.1%$0.965$0.965$0.90737,900
$0.966-0.006-0.6%$0.966$0.998$0.9381,780,500
$0.9720.000.0%$1.01$1.03$0.96676,500
$0.972+0.081+9.1%$0.918$1.00$0.911,145,000
$0.891-0.015-1.7%$0.901$0.968$0.88945,000
$0.906-0.114-11.2%$1.01$1.02$0.9011,233,400
$1.02+0.03+3.0%$1.00$1.04$0.994826,900
$0.99-0.13-11.6%$1.12$1.127$0.9731,962,000
$1.12+0.192+20.7%$0.944$1.14$0.9323,885,700
$0.928+0.023+2.5%$0.907$0.996$0.891,072,100
$0.905-0.015-1.6%$0.908$0.95$0.89576,100
$0.92-0.042-4.4%$0.98$0.98$0.895795,200
$0.962+0.035+3.8%$0.941$0.99$0.92834,700
$0.927-0.045-4.6%$0.961$0.972$0.915565,000
$0.972+0.086+9.7%$0.90$0.98$0.89782,000
$0.886-0.018-2.0%$0.90$0.92$0.872484,100
$0.904-0.033-3.5%$0.95$0.985$0.90522,500
$0.937+0.056+6.4%$0.922$0.95$0.91860,900
$0.881+0.006+0.7%$0.89$0.918$0.861484,200
$0.875-0.08-8.4%$0.98$0.98$0.862606,900
$0.955+0.053+5.9%$0.92$0.978$0.89852,100
$0.9020.000.0%$0.89$0.93$0.876496,200
$0.902+0.05+5.9%$0.885$0.92$0.87515,700
$0.852-0.029-3.3%$0.881$0.885$0.845487,300
$0.881-0.011-1.2%$0.88$0.91$0.86487,200
$0.892+0.002+0.2%$0.90$0.91$0.86630,300
$0.89-0.01-1.1%$0.912$0.924$0.882498,100
$0.90+0.009+1.0%$0.891$0.915$0.875608,500
$0.891+0.026+3.0%$0.888$0.926$0.865328,100
$0.865-0.035-3.9%$0.91$0.97$0.86823,200
$0.90+0.014+1.6%$0.886$0.941$0.841916,800
$0.886-0.044-4.7%$0.941$0.95$0.8641,038,900
$0.93-0.055-5.6%$1.00$1.02$0.92871,400
$0.985-0.025-2.5%$1.02$1.055$0.981,866,900
$1.01+0.033+3.4%$1.00$1.03$0.9651,224,600
$0.977-0.053-5.1%$1.02$1.06$0.95925,000
$1.03-0.01-1.0%$1.04$1.07$1.001,215,600
$1.04-0.16-13.3%$1.21$1.235$1.021,772,000
$1.20-0.46-27.7%$1.60$1.63$1.152,127,000
$1.66-0.03-1.8%$1.71$1.74$1.65436,500
$1.69-0.08-4.5%$1.77$1.785$1.68624,400
$1.77+0.07+4.1%$1.70$1.79$1.70528,600
$1.700.000.0%$1.68$1.72$1.665425,000
$1.70+0.01+0.6%$1.69$1.72$1.66409,100
$1.69-0.05-2.9%$1.75$1.79$1.68307,000
Ticker
NASDAQ:NAUT
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Upcoming

  • Nautilus Biotechnology (NASDAQ:NAUT) Q3 2026 Earnings Call

    Tue, Oct 27, 2026 · 8:30 AM ET

    Register

Replays

  • Nautilus Biotechnology (NASDAQ:NAUT) Q2 2026 Earnings Call

    Tue, Jul 28, 2026 · 8:30 AM ET

    Watch Transcript

  • Nautilus Biotechnology (NASDAQ:NAUT) Q1 2026 Earnings Call

    Tue, Apr 28, 2026 · 8:30 AM ET

    Watch Transcript

  • Nautilus Biotechnology (NASDAQ:NAUT) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

Oct 15, 2026

Closed $2.16 (0.0%) on Oct 15, 2026

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Jul 28, 2026

Closed $1.20 (-27.7%) on Jul 28, 2026

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026

Jul 8, 2026

Closed $1.78 (+5.3%) on Jul 8, 2026

Nautilus Biotechnology Reports First Quarter 2026 Financial Results

Apr 28, 2026

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

Apr 9, 2026

Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

Mar 24, 2026

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

Mar 20, 2026

Issued by another party

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

Mar 18, 2026

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

Mar 2, 2026

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Feb 26, 2026

All Nautilus Biotechnology, Inc. news

Decks

Nautilus Biotechnology, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 63 in all · newest Oct 15, 2026 · oldest 2021
Calls
21 calls with a replay · 21 with a transcript · latest Jul 28, 2026
Decks
3 decks · latest Apr 7, 2021

Where Nautilus Biotechnology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NAUT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:NAUTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Nautilus Biotechnology, Inc.